Bladder cancer (BLCA) is a common malignancy of the urinary system, yet the therapeutic relevance of transient receptor potential cation channel subfamily M member 4 (TRPM4) remains unclear. This evidence concerns the gene TRPM4 and bladder transitional cell carcinoma.